Journal of the National Cancer Institute logo Oxford University Press logo

JNCI - Journal of the National Cancer Institute publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as the most-cited original-research cancer journal by the Institute of Scientific Information in its annual Journal Citation Reports. The Journal of the National Cancer Institute's impact factor for 2005, as reported in 2006, was 15.171.

Publisher: Oxford University Press

More like this?
Volume 96, Number 21, 3 November 2004
Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial

< previous issue | next issue > | all issues

Press Release
pp. 1563-1563(1)
Author: Sarah L. Zielinski

In This Issue
pp. 1563-1563(1)

Could Exposure Assessment Problems Give Us Wrong Answers to Nutrition and Cancer Questions?
pp. 1564-1565(2)
Authors: Arthur Schatzkin; Victor Kipnis

Nanotechnology Grows Into Billion-Dollar Enterprise
pp. 1566-1567(2)
Author: Brian Vastag

Canadian Province Seeks Control of Its Genes
pp. 1567-1569(3)
Author: Robert Longtin

Stat Bite: Estimated Deaths Attributable to Variations in Health Care
pp. 1569-1569(1)

Researchers Optimistic About Targeted Drugs for Pancreatic Cancer
pp. 1570-1572(3)
Author: Gail McBride

Screening Methods May Offer Early Diagnosis of Pancreatic Cancer
pp. 1571-1571(1)
Author: Gail McBride

In Brief
pp. 1572-1572(1)
Authors: Kate Travis; Sarah L. Zielinski

Good Drug, Bad Luck: Business, Regulatory Issues Can Create Obstacles for Drug Development
pp. 1573-1574(2)
Author: Bruce Goldman

Last Decade Brought New Guidelines, Detection Methods for Colon Cancer Screening
pp. 1575-1575(1)
Author: Sarah L. Zielinski

Awards, Appointments, Announcements
pp. 1576-1576(1)

Fruit and Vegetable Intake and Risk of Major Chronic Disease
pp. 1577-1584(8)
Authors: Hsin-Chia Hung; Kaumudi J. Joshipura; Rui Jiang; Frank B. Hu; David Hunter; Stephanie A. Smith-Warner; Graham A. Colditz; Bernard Rosner; Donna Spiegelman; Walter C. Willett

Prediction of Irinotecan Pharmacokinetics by Use of Cytochrome P450 3A4 Phenotyping Probes
pp. 1585-1592(8)
Authors: Ron H. J. Mathijssen; Floris A. de Jong; Ron H. N. van Schaik; Erin R. Lepper; Lena E. Friberg; Trinet Rietveld; Peter de Bruijn; Wilfried J. Graveland; William D. Figg; Jaap Verweij; Alex Sparreboom

Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents
pp. 1593-1603(11)
Authors: Matus Studeny; Frank C. Marini; Jennifer L. Dembinski; Claudia Zompetta; Maria Cabreira-Hansen; Benjamin Nebiyou Bekele; Richard E. Champlin; Michael Andreeff

Synergistic Antitumor Activity of Histamine Plus Melphalan in Isolated Limb Perfusion: Preclinical Studies
pp. 1603-1610(8)
Authors: Flavia Brunstein; Saske Hoving; Ann L. B. Seynhaeve; Sandra T. van Tiel; Gunther Guetens; Ernst A. de Bruijn; Alexander M. M. Eggermont; Timo L. M. ten Hagen

Impaired Antigen Presentation and Effectiveness of Combined Active/Passive Immunotherapy for Epithelial Tumors
pp. 1611-1619(9)
Authors: Koji Matsumoto; Graham R. Leggatt; Jie Zhong; Xiaosong Liu; Rachel L. de Kluyver; Tania Peters; Germain J. P. Fernando; Amy Liem; Paul F. Lambert; Ian H. Frazer

Transferrin-Conjugated Liposome Targeting of Photosensitizer AlPcS4 to Rat Bladder Carcinoma Cells
pp. 1620-1630(11)
Authors: Annelies S. L. Derycke; Appolinary Kamuhabwa; Antoon Gijsens; Tania Roskams; Dirk De Vos; Ahmad Kasran; Jörg Huwyler; Ludwig Missiaen; Peter A. M. de Witte

Association Between Biallelic and Monoallelic Germline MYH Gene Mutations and Colorectal Cancer Risk
pp. 1631-1634(4)
Authors: Marina E. Croitoru; Sean P. Cleary; Nando Di Nicola; Michael Manno; Teresa Selander; Melyssa Aronson; Mark Redston; Michelle Cotterchio; Julia Knight; Robert Gryfe; Steven Gallinger

Anthropometry, Physical Activity, and Endometrial Cancer Risk: Results From The Netherlands Cohort Study
pp. 1635-1638(4)
Authors: Leo J. Schouten; R. Alexandra Goldbohm; Piet A. van den Brandt

RESPONSE: Re: Influence of the New AJCC Breast Cancer Staging System on Sentinel Lymph Node Positivity and False-Negative Rates
pp. 1639-1640(2)
Author: David R. McCready

Re: Influence of the New AJCC Breast Cancer Staging System on Sentinel Lymph Node Positivity and False-Negative Rates
pp. 1639-1639(1)
Author: Carl D. Atkins

Re: Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis
pp. 1640-1640(1)
Author: Boguslaw Lipinski

Erratum
pp. 1640-1640(1)

< previous issue | next issue > | all issues

Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in
Need to register?
Sign up here
Text size: A | A | A | A